Profiles in leukemia

New England Journal of Medicine

Volumn 366, Issue 12, 2012, Pages 1152-1153

  Godley, Lucy A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DASATINIB;

ACUTE GRANULOCYTIC LEUKEMIA; ASXL1 GENE; CANCER GROWTH; CANCER SURVIVAL; CDH23 GENE; CEBPA GENE; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNMT3A GENE; DRUG EFFICACY; EDITORIAL; FLT3 GENE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE REARRANGEMENT; HIGH THROUGHPUT SEQUENCING; HUMAN; IDH2 GENE; MICROARRAY ANALYSIS; MLL GENE; MOLECULAR CLONING; MOLECULAR PATHOLOGY; MYELODYSPLASTIC SYNDROME; NPM1 GENE; ONCOGENE; OUTCOME ASSESSMENT; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SMC3 GENE; SURVIVAL RATE; UMODL1 GENE; ZSWIM4 GENE;

EID: 84858638813     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1200409     Document Type: Editorial

References (5)

1. Walter MJ, Shen D, Ding L, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 2012;366:1090-8.
2. Patel JP, Gönen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012;366:1079-89.
3. Bejar R, Stevenson K, Abdel-Wahab O, et al. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 2011;364:2496-506.
4. Welch JS, Westervelt P, Ding L, et al. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA 2011; 305:1577-84.
5. Sledge GW Jr. The challenge and promise of the genomic era. J Clin Oncol 2012;30:203-9.